Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 7, 2014; 20(37): 13306-13324
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13306
Figure 1
Figure 1 Common features in nonalcoholic fatty liver disease and cardiovascular disease. NAFLD: Nonalcoholic fatty liver disease; CVD: Cardiovascular disease.
Figure 2
Figure 2 Mechanisms potentially responsible for atherosclerosis in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. NASH: Non-alcoholic steatohepatitis.
Figure 3
Figure 3 Causes and consequences of the procoagulant imbalance in patients with nonalcoholic fatty liver disease. ETP-ratio: Ratio of the endogenous thrombin potential measured in the presence or absence of thrombomodulin; PICI: Protac®-induced coagulation inhibition.